The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Tetramer formation of tumor suppressor protein p53: Structure, function, and applications
Abstract
Tetramer formation of p53 is essential for its tumor suppressor function. p53 not only acts as a tumor suppressor protein by inducing cell cycle arrest and apoptosis in response to genotoxic stress, but it also regulates other cellular processes, including autophagy, stem cell self‐renewal, and reprogramming of differentiated cells into stem cells, immune system, and metastasis. More than 50% of human tumors have TP53 gene mutations, and most of them are missense mutations that presumably reduce tumor suppressor activity of p53. This review focuses on the role of the tetramerization (oligomerization), which is modulated by the protein concentration of p53, posttranslational modifications, and/or interactions with its binding proteins, in regulating the tumor suppressor function of p53. Functional control of p53 by stabilizing or inhibiting oligomer formation and its bio‐applications are also discussed. © 2015 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 106: 598–612, 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“R337C/H/P and L344P affect the formation and transcriptional activity of p53 tetramers and are involved in Li-Fraumeni Syndrome and Li-Fraumeni-Like Syndrome.316”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [316]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204
Self-citationCytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007
p73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Vaseva, A. V., Marchenko, N. D., Ji, K., Tsirka, S. E., Holzmann, S., & Moll, U. M. (2012) · Cell · doi:10.1016/j.cell.2012.05.014 · Cited by 740
p53 status determines the role of autophagy in pancreatic tumour development
Rosenfeldt, M. T., O’Prey, J., Morton, J. P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T. S., Zheng, L., Ridgway, R., et al. (2013) · Nature · doi:10.1038/nature12865 · Cited by 713
How p53 binds DNA as a tetramer
McLure, K. G., & Lee, P. W. K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3342 · Cited by 260
Yakovlev, V. A., Bayden, A. S., Graves, P. R., Kellogg, G. E., & Mikkelsen, R. B. (2010) · Biochemistry · doi:10.1021/bi100564w · Cited by 56
Research works printed but not linked: 137
- 10.1073/pnas.76.5.2420 · DOI · Paper page
- 10.1038/278261a0 · DOI · Paper page
- 10.1016/0092-8674(79)90293-9 · DOI · Paper page
- 10.1101/gad.4.1.1 · DOI · Paper page
- 10.1038/nrc2716 · DOI · Paper page
- 10.1038/nrc3711 · DOI · Paper page
- 10.1002/bies.950151008 · DOI · Paper page
- 10.1126/science.1261669 · DOI · Paper page
- 10.1093/jmcb/mju018 · DOI
- 10.1096/fj.10-160549 · DOI · Paper page
- 10.4049/jimmunol.0803526 · DOI
- 10.1146/annurev.biochem.77.060806.091238 · DOI · Paper page
- 10.1074/jbc.M011644200 · DOI
- 10.1073/pnas.92.21.9455 · DOI · Paper page
- 10.1073/pnas.92.19.8591 · DOI
- 10.1038/onc.2008.400 · DOI
- 10.1016/j.molmed.2010.09.002 · DOI · Paper page
- Meek D. W., 2009, Csh Perspect Biol, 1
- 10.1093/emboj/18.7.1815 · DOI · Paper page
- 10.1074/jbc.M805696200 · DOI
- 10.1038/nsmb.1521 · DOI
- 10.1016/j.biocel.2010.01.010 · DOI
- 10.1038/sj.onc.1204373 · DOI · Paper page
- 10.1074/jbc.M901351200 · DOI
- 10.1073/pnas.90.13.5954 · DOI
- 10.1074/jbc.274.15.10539 · DOI
- 10.1128/MCB.20.3.741-748.2000 · DOI
- 10.4161/cbt.6.10.4719 · DOI
- 10.1093/emboj/18.6.1660 · DOI · Paper page
- 10.1246/bcsj.64.111 · doi:10.1246/bcsj.64.111
- 10.1246/bcsj.65.3055 · doi:10.1246/bcsj.65.3055
- 10.1073/pnas.91.19.8974 · DOI · Paper page
- 10.1038/nsb0495-321 · DOI · Paper page
- 10.1002/pro.5560040505 · DOI · Paper page
- 10.1038/nsb1294-877 · DOI · Paper page
- 10.1126/science.7878469 · DOI · Paper page
- 10.1016/S0014-5793(96)01231-8 · DOI
- 10.1021/bi00016a002 · DOI
- 10.1002/j.1460-2075.1995.tb07027.x · DOI
- 10.1073/pnas.1311126110 · DOI
- 10.1016/S1097-2765(00)80275-0 · DOI · Paper page
- 10.1038/sj.emboj.7601764 · DOI
- 10.1038/cdd.2009.139 · DOI
- 10.1073/pnas.0905867106 · DOI
- 10.1186/1471-2164-10-628 · DOI · Paper page
- 10.1016/j.gene.2008.11.029 · DOI
- Belyi V. A., 2010, J. Csh Perspect Biol, 2
- 10.1016/j.str.2014.07.010 · DOI · Paper page
- 10.1093/emboj/17.10.2748 · DOI
- 10.1038/nsb730 · DOI · Paper page
- 10.1016/j.jmb.2007.07.080 · DOI
- 10.1038/5880 · DOI
- 10.1046/j.1432-1327.2001.02414.x · doi:10.1046/j.1432-1327.2001.02414.x
- 10.1073/pnas.0907840106 · DOI
- 10.1126/science.1905840 · DOI · Paper page
- 10.1038/351453a0 · DOI · Paper page
- 10.1093/nar/gks1033 · DOI · Paper page
- 10.1002/humu.22559 · DOI
- 10.1371/journal.pone.0069026 · DOI
- 10.1038/sj.onc.1201133 · DOI
- 10.1002/humu.1380110121 · DOI
- 10.1054/bjoc.2000.1167 · DOI · Paper page
- 10.1016/j.canlet.2005.12.039 · DOI · Paper page
- 10.1136/jmg.2004.030551 · DOI · Paper page
- 10.3109/08880011003663374 · DOI
- 10.1016/j.ejca.2005.11.032 · DOI · Paper page
- 10.1074/jbc.M110.174698 · DOI
- 10.1021/bi051192j · DOI · Paper page
- 10.1016/S0022-2836(03)00175-X · DOI
- 10.1110/ps.051622005 · DOI
- 10.1073/pnas.1431692100 · DOI · Paper page
- 10.1002/humu.20114 · DOI
- 10.1016/j.ab.2009.01.030 · DOI
- 10.4161/cc.8.20.9910 · DOI
- 10.1101/gad.10.9.1054 · DOI · Paper page
- 10.1074/jbc.M108815200 · DOI
- 10.1128/MCB.24.8.3536-3551.2004 · DOI · Paper page
- 10.1016/j.jmb.2009.11.013 · DOI
- 10.1073/pnas.93.9.4091 · DOI · Paper page
- Levine A., 1997, J. Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- 10.1038/sj.onc.1207396 · DOI · Paper page
- 10.1101/gad.190678.112 · DOI · Paper page
- 10.1038/ncb2641 · DOI · Paper page
- 10.1093/carcin/bgs232 · DOI · Paper page
- 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- 10.18632/oncotarget.2587 · DOI
- 10.1038/sj.onc.1201857 · DOI
- 10.1016/j.cell.2004.11.006 · DOI · Paper page
- 10.1073/pnas.1500262112 · DOI · Paper page
- 10.1021/bi970759w · DOI · Paper page
- 10.1016/j.febslet.2004.07.014 · DOI
- 10.1016/S0092-8674(05)80007-8 · DOI · Paper page
- 10.1016/j.jmb.2012.10.015 · DOI
- 10.1021/bi301193k · DOI
- 10.1074/jbc.M113.474049 · DOI
- 10.1016/j.febslet.2005.12.025 · doi:10.1016/j.febslet.2005.12.025
- 10.1093/nar/gkn598 · DOI
- 10.1093/nar/gkp516 · DOI · Paper page
- 10.1111/cpr.12150 · DOI
- 10.1016/j.neo.2014.07.008 · DOI
- 10.1074/jbc.M505772200 · DOI
- 10.1016/j.molonc.2014.04.002 · DOI
- 10.1002/bip.21084 · DOI
- 10.1073/pnas.89.23.11627 · DOI · Paper page
- 10.1073/pnas.0501459102 · DOI · Paper page
- 10.1073/pnas.0710017104 · DOI
- 10.1074/jbc.M113.527978 · DOI
- 10.15252/msb.20145168 · DOI
- 10.1093/nar/gku1075 · DOI · Paper page
- 10.1038/sj.cdd.4402301 · DOI
- 10.1073/pnas.241629998 · DOI · Paper page
- 10.1126/science.286.5449.2507 · DOI · Paper page
- 10.1101/cshperspect.a000919 · DOI · Paper page
- 10.1002/anie.200352115 · DOI
- 10.1002/cbic.200500555 · DOI
- 10.1073/pnas.0805658105 · DOI
- 10.1002/asia.201000938 · DOI
- 10.1016/j.bmcl.2010.06.053 · DOI
- 10.1074/jbc.M208528200 · DOI
- 10.1021/mp400379c · DOI
- 10.1038/nm.2144 · DOI · Paper page
- 10.1016/j.tcb.2009.12.004 · DOI
- 10.1016/B978-0-12-800097-7.00005-1 · DOI
- 10.1016/j.bmcl.2012.02.085 · DOI
- 10.1002/anie.200903572 · DOI · Paper page
- 10.1021/cr8002328 · DOI · Paper page
- 10.1039/C4CC04350B · doi:10.1039/c4cc04350b
- 10.1016/S1380-2933(97)00067-5 · DOI · Paper page
- 10.1074/jbc.M011669200 · doi:10.1074/jbc.m011669200
- 10.1016/j.pep.2015.07.009 · DOI
- 10.1016/j.jbiotec.2006.11.001 · DOI
- 10.1042/BST20120025 · DOI
- 10.1021/bi051338e · DOI
- 10.1021/bc900075p · doi:10.1021/bc900075p
- 10.1002/bip.21594 · DOI
- 10.1002/prot.21854 · DOI
- 10.1016/j.jmb.2006.10.051 · DOI
Cited by
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Mustafa, M., Ahmad, R., Tantry, I. Q., Ahmad, W., Siddiqui, S., Alam, M., Abbas, K., Moinuddin, Hassan, M. I., Habib, S., et al. (2024) · Cells · doi:10.3390/cells13221838 · Cited by 595
Low, L., Goh, A., Koh, J., Lim, S., & Wang, C.-I. (2019) · Nature Communications · doi:10.1038/s41467-019-13305-z · Cited by 48
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Metadata
- Authors
- Kamada, R., Toguchi, Y., Nomura, T., Imagawa, T., & Sakaguchi, K.
- Affiliations
- Laboratory of Biological Chemistry, Department of Chemistry, Faculty of Science Hokkaido University Sapporo 060‐0810 Japan
- Center for Research and Education on Drug Discovery Faculty of Pharmaceutical Sciences, Hokkaido University Sapporo 060‐0812 Japan
- Venue
- Peptide Science
- Publisher
- Wiley
- Published
- 2016-07
- Volume
- 106
- Issue
- 4
- Pages
- 598-612
- ISSN
- 0006-3525
- Cited by
- 105
- References
- 15
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.